Literature DB >> 5354875

Handling of induced hypercalcaemia in hyperthyroidism.

P Lim, E Jacob, O T Khoo.   

Abstract

The mean serum calcium of 13 hyperthyroid patients was found to be significantly higher than that of controls matched for sex and age, though none of the patients' values were outside the normal range. Nevertheless, these patients responded very promptly to hypercalcaemia (induced by an intravenous calcium load), and their serum calcium returned to normal much more rapidly compared with the matched controls. There was also increased retention of intravenous calcium load, possibly owing to increased calcitonin production. Calcium infusion may be useful in treating bone diseases in which increased bone resorption exceeds bone accretion.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5354875      PMCID: PMC1630122          DOI: 10.1136/bmj.4.5685.715

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  12 in total

1.  OSTEOMALACIA IN THYROTOXICOSIS.

Authors:  E P CLERKIN; H G HAAS; D H MINTZ; C R MELONI; J J CANARY
Journal:  Metabolism       Date:  1964-02       Impact factor: 8.694

2.  Metabolic observations in a case of thyrotoxicosis with hypercalcemia.

Authors:  C R KLEEMAN; S TUTTLE; S H BASSETT
Journal:  J Clin Endocrinol Metab       Date:  1958-05       Impact factor: 5.958

3.  Hypercalcemia, nephrocalcinosis and reversible renal insufficiency associated with hyperthyroidism.

Authors:  F H EPSTEIN; L R FREEDMAN; H LEVITIN
Journal:  N Engl J Med       Date:  1958-04-17       Impact factor: 91.245

4.  The effect of thyroid disease on calcium metabolism in man.

Authors:  S M KRANE; G L BROWNELL; J B STANBURY; H CORRIGAN
Journal:  J Clin Invest       Date:  1956-08       Impact factor: 14.808

5.  RELATION OF THYROID AND PARATHYROID GLANDS TO CALCIUM AND PHOSPHORUS METABOLISM. STUDY OF A CASE WITH COEXISTENT HYPOPARATHYROIDISM AND HYPERTHYROIDISM.

Authors:  O Cope; G A Donaldson
Journal:  J Clin Invest       Date:  1937-05       Impact factor: 14.808

6.  STUDIES OF CALCIUM AND PHOSPHORUS METABOLISM: VI. In Hypoparathyroidism and Chronic Steatorrhea with Tetany with Special Consideration of the Therapeutic Effect of Thyroid.

Authors:  J C Aub; F Albright; W Bauer; E Rossmeisl
Journal:  J Clin Invest       Date:  1932-01       Impact factor: 14.808

7.  Plasma levels of ionised calcium and magnesium in thyroid disease.

Authors:  D Frizel; A Malleson; V Marks
Journal:  Lancet       Date:  1967-06-24       Impact factor: 79.321

8.  Thyrocalcitonin activity in hypercalcemia produced by calcium salts, parathyroid hormone and vitamin D.

Authors:  R Mittleman; A Chausmer; J Bellavia; S Wallach
Journal:  Endocrinology       Date:  1967-09       Impact factor: 4.736

9.  Effects of calcitonin on patients with Paget's disease, thyrotoxicosis, or hypercalcaemia.

Authors:  O L Bijvoet; J van der Sluys Veer; A P Jansen
Journal:  Lancet       Date:  1968-04-27       Impact factor: 79.321

10.  Assay of calcitonin in human plasma.

Authors:  W C Sturtridge; M A Kumar
Journal:  Lancet       Date:  1968-04-06       Impact factor: 79.321

View more
  1 in total

1.  Hypercalcaemia in thyrotoxicosis with and without hyperparathyroidism.

Authors:  A J Richards
Journal:  Postgrad Med J       Date:  1970-07       Impact factor: 2.401

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.